uk 68798 has been researched along with Disease Models, Animal in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (27.66) | 18.2507 |
2000's | 20 (42.55) | 29.6817 |
2010's | 13 (27.66) | 24.3611 |
2020's | 1 (2.13) | 2.80 |
Authors | Studies |
---|---|
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Hamlin, RL; Kijtawornrat, A; Limprasutr, V; Meedech, P; Saengklub, N | 1 |
Buhl, R; Carstensen, H; Flethøj, M; Haugaard, MM; Hesselkilde, EZ; Jespersen, T; Kanters, JK; Kjær, L; Pehrson, S | 1 |
Buhl, R; Carlson, J; Carstensen, H; Flethøj, M; Haugaard, MM; Hesselkilde, EZ; Jespersen, T; Pehrson, S; Platonov, PG | 1 |
Beekman, JD; Tieland, RG; van der Heyden, MA; Varkevisser, R; Vos, MA | 2 |
Beekman, HD; Bourgonje, VJ; Oosterhoff, P; Schoenmakers, M; Stams, TR; van der Nagel, R; van Opstal, JM; Vos, MA | 1 |
Kim, JJ; Li, Q; Němec, J; Salama, G | 1 |
Anyukhovsky, EP; Chauveau, S; Cohen, IS; Coronel, R; Feinmark, SJ; Harleton, E; Janse, MJ; Jiang, YP; Lin, RZ; Opthof, T; Qiu, XS; Rahim, T; Rosen, MR; Rosen, TS | 1 |
Dhein, S; Mohr, FW; Perlitz, F | 1 |
David, M; Dujardin, KS; Dumotier, B; Guizy, M; Hondeghem, LM; Valenzuela, C | 1 |
Gong, PL; Liu, QN; Yang, XY; Zeng, FD; Zhang, L | 1 |
Dai, DZ; Dai, Y; Hamed, KH; Hu, C; Yu, F | 1 |
Beekman, JD; de Boer, TP; Duker, G; Houtman, MJ; Jonsson, MK; Nalos, L; Peschar, M; Rook, MB; Sartipy, P; Thomsen, MB; van der Heyden, MA; van der Nagel, R; van Veen, TA; Varkevisser, R; Vos, MA | 1 |
Carlsson, LG; Crijns, HJ; de Jong, MM; Johnson, DM; Volders, PG | 1 |
Antoons, G; Beekman, JD; Bourgonje, VJ; de Windt, LJ; Houtman, MJ; Miedema, LF; Schoenmakers, M; Sipido, K; van der Nagel, R; van Veen, TA; Vos, MA | 1 |
Crijns, HJ; Vos, MA | 1 |
Duff, HJ; Guo, J; Lees-Miller, JP; Rancourt, DE; Roach, DE; Sheldon, RS; Somers, JR | 1 |
Bauer, A; Becker, R; Donahue, JK; Katus, HA; Kelemen, K; Kraft, P; Schoels, W; Senges, JC; Voss, F | 1 |
Chandra, P; Danilo, P; Kim, HY; Lee, K; Rosen, MR; Rosen, TS; Yeom, ZH | 1 |
Carlsson, L; Kowey, PR; Liu, T; Wu, Y; Yan, GX | 1 |
Bradley, JA; Cass, JD; Chen, X; Dahm, CM; Engwall, MJ; Kadyszewski, E; Sun, Z; Zhou, J | 1 |
Cvetanovic, I; Ke, X; Lin, C; Ranade, V; Somberg, J | 1 |
Beekman, JD; Oros, A; van der Nagel, T; Volders, PG; Vos, MA | 1 |
Brendel, J; Gögelein, H; Linz, DK; Rütten, H; Steinmeyer, K; Wirth, KJ | 1 |
Chartier, D; Diness, TG; Grunnet, M; Hansen, RS; Nattel, S; Olesen, SP; Qi, XY; Tsuji, Y; Yeh, YH | 1 |
De Clerck, F; Lu, HR; Remeysen, P | 1 |
Chi, L; Friedrichs, GS; Green, AL; Lucchesi, BR | 1 |
Andersen, HR; Christiansen, N; Knudsen, LL; Simonsen, I; Thomsen, PE; Wiggers, H | 1 |
Bril, A; Feuerstein, GZ; Gout, B; Nichols, AJ | 1 |
Cha, Y; Feld, GK; Sawhney, N; Shahrokni, S; Wales, A; Wolf, P | 1 |
Chen, J; Eto, K; Hashimoto, K; Ni, C; Xue, Y | 1 |
Cantù, F; Napolitano, C; Paganini, V; Priori, SG; Schwartz, PJ | 1 |
Cobbe, SM; Kane, KA; McIntosh, MA; Rankin, AC | 1 |
Chiba, S; Furukawa, Y; Hoyano, Y; Imamura, H; Kasama, M; Yonezawa, T | 1 |
Gillis, AM; Kulisz, E; Lester, WM; Mathison, HJ | 1 |
Carnes, CA; Mehdirad, AA; Nelson, SD | 1 |
Beatch, GN; Davis, DR; Dickenson, DR; Tang, AS | 1 |
Al-Khalidi, H; Brooks, RR; Drexler, AP; Kostreva, DR; Maynard, AE | 1 |
Bénardeau, A; Li, D; Nattel, S | 1 |
DiMarco, JP; Mounsey, JP | 1 |
Doshi, SK; Singh, BN | 1 |
Leunissen, JD; Van Opstal, JM; Vos, MA; Wellens, HJ | 1 |
De Clerck, F; Lu, HR; Remeysen, P; Saels, A; Somers, K | 1 |
El-Sherif, N; Kozhevnikov, DO; Restivo, M; Robotis, D; Yamamoto, K | 1 |
Doggrell, SA; Nand, V | 1 |
5 review(s) available for uk 68798 and Disease Models, Animal
Article | Year |
---|---|
Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disease Models, Animal; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes | 2001 |
Molecular biology of the long QT syndrome: impact on management.
Topics: Action Potentials; Adrenergic Antagonists; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiotonic Agents; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 7; Disease Models, Animal; Electrocardiography; Genetic Therapy; Guinea Pigs; Heart Rate; Humans; Intercellular Signaling Peptides and Proteins; Long QT Syndrome; Mexiletine; Molecular Biology; Myocardium; Peptides; Phenethylamines; Potassium; Potassium Channel Blockers; Potassium Channels; Receptors, Adrenergic; Risk Factors; Sodium Channel Blockers; Sodium Channels; Sulfonamides; Syncope; Tachycardia, Ventricular | 1997 |
Dofetilide enhances shock-induced extension of refractoriness and lowers defibrillation threshold.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Electric Countershock; Humans; Phenethylamines; Shock, Cardiogenic; Sulfonamides | 1999 |
Cardiovascular drugs. Dofetilide.
Topics: Action Potentials; Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Controlled Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Phenethylamines; Potassium; Potassium Channel Blockers; Potassium Channels; Reaction Time; Sulfonamides; Treatment Outcome; Ventricular Fibrillation | 2000 |
Pure class III antiarrhythmic drugs: focus on dofetilide.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Electrophysiology; Heart Failure; Humans; Phenethylamines; Sulfonamides | 2000 |
1 trial(s) available for uk 68798 and Disease Models, Animal
Article | Year |
---|---|
Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disease Models, Animal; Electrocardiography; Myocardial Ischemia; Phenethylamines; Potassium Channels; Sulfonamides; Swine; Ventricular Fibrillation | 1994 |
41 other study(ies) available for uk 68798 and Disease Models, Animal
Article | Year |
---|---|
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Characteristics of electromechanical window in anesthetized rabbit models of short QT and long QT syndromes.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Benzopyrans; Biomarkers; Biomarkers, Pharmacological; Cromakalim; Disease Models, Animal; Electrocardiography; Isoflurane; Long QT Syndrome; Phenethylamines; Pinacidil; Quinidine; Rabbits; Risk; Sulfonamides; Systole; Torsades de Pointes; Ventricular Pressure | 2017 |
Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Drug Combinations; Female; Heart Rate; Horses; Infusions, Intravenous; Male; Phenethylamines; Ranolazine; Sulfonamides | 2018 |
Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Horses; Male; Phenethylamines; Potassium Channel Blockers; Ranolazine; Sodium Channel Blockers; Sulfonamides; Time Factors | 2019 |
Vernakalant is devoid of proarrhythmic effects in the complete AV block dog model.
Topics: Animals; Anisoles; Anti-Arrhythmia Agents; Atrioventricular Block; Disease Models, Animal; Dogs; Female; Male; Phenethylamines; Pyrrolidines; Sulfonamides; Torsades de Pointes | 2013 |
The electromechanical window is no better than QT prolongation to assess risk of Torsade de Pointes in the complete atrioventricular block model in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Remodeling; Atrioventricular Block; Databases, Factual; Delayed Rectifier Potassium Channels; Disease Models, Animal; Disease Susceptibility; Dogs; Early Diagnosis; Electrocardiography; Female; Heart; Heart Rate; Male; Phenethylamines; Potassium Channel Blockers; Reproducibility of Results; Sulfonamides; Torsades de Pointes | 2014 |
AV-block and conduction slowing prevail over TdP arrhythmias in the methoxamine-sensitized pro-arrhythmic rabbit model.
Topics: Action Potentials; Anesthetics; Animals; Anti-Arrhythmia Agents; Atrioventricular Block; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Flunarizine; Heart Conduction System; Heart Rate; Methoxamine; Phenethylamines; Rabbits; Sulfonamides; Time Factors; Torsades de Pointes | 2015 |
Synchronous systolic subcellular Ca2+-elevations underlie ventricular arrhythmia in drug-induced long QT type 2.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Signaling; Disease Models, Animal; Female; Heart Rate; In Vitro Techniques; Long QT Syndrome; Myocytes, Cardiac; Perfusion; Phenethylamines; Rabbits; Sarcoplasmic Reticulum; Sulfonamides; Thiazepines; Time Factors; Voltage-Sensitive Dye Imaging | 2015 |
Increased Late Sodium Current Contributes to the Electrophysiological Effects of Chronic, but Not Acute, Dofetilide Administration.
Topics: Animals; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Heart Ventricles; Infusions, Intravenous; Long QT Syndrome; Male; Patch-Clamp Techniques; Phenethylamines; Potassium Channel Blockers; Sodium; Sulfonamides | 2016 |
An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Haloperidol; Heart; Heart Rate; In Vitro Techniques; Phenethylamines; Rabbits; Sulfonamides; Torsades de Pointes | 2008 |
Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Diet; Disease Models, Animal; Docosahexaenoic Acids; Female; Heart Conduction System; Kinetics; Perfusion; Phenethylamines; Rabbits; Sodium Channel Blockers; Sodium Channels; Sulfonamides; Torsades de Pointes | 2008 |
Daurisoline suppressed early afterdepolarizations and inhibited L-type calcium current.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Benzylisoquinolines; Calcium Channels, L-Type; Calcium Signaling; Cardiomegaly; Disease Models, Animal; Heart; Menispermum; Muscle Cells; Patch-Clamp Techniques; Phenethylamines; Phytotherapy; Plant Extracts; Potassium; Rabbits; Rhizome; Sulfonamides; Time Factors | 2010 |
CPU228, a derivative of dofetilide, relieves cardiac dysfunction by normalizing FKBP12.6, NADPH oxidase and protein kinase C epsilon in the myocardium.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Heart Failure; Isoproterenol; Male; NADPH Oxidases; Naphthalenes; Oxidative Stress; Phenethylamines; Phosphorylation; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Sulfonamides; Tacrolimus Binding Proteins; Up-Regulation | 2010 |
Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Aza Compounds; Cell Line; Disease Models, Animal; Dogs; Embryonic Stem Cells; Female; Fluoroquinolones; Heart; Heart Block; Humans; Methoxamine; Moxifloxacin; Myocytes, Cardiac; Phenethylamines; Piperidines; Potassium Channel Blockers; Pyridines; Quinolines; Rabbits; Sulfonamides; Torsades de Pointes; Ventricular Remodeling | 2012 |
Reduced ventricular proarrhythmic potential of the novel combined ion-channel blocker AZD1305 versus dofetilide in dogs with remodeled hearts.
Topics: Animals; Atrioventricular Block; Azabicyclo Compounds; Carbamates; Disease Models, Animal; Dogs; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studies; Heart Rate; Male; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Treatment Outcome; Ventricular Remodeling | 2012 |
Relevance of calmodulin/CaMKII activation for arrhythmogenesis in the AV block dog.
Topics: Animals; Arrhythmias, Cardiac; Atrioventricular Block; Benzylamines; Calcineurin; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomyopathy, Hypertrophic; Cyclosporine; Disease Models, Animal; Dogs; Isoproterenol; Long QT Syndrome; Myocytes, Cardiac; Patch-Clamp Techniques; Phenethylamines; Phenotype; Phosphorylation; Random Allocation; Sulfonamides; Ventricular Remodeling | 2012 |
Selective knockout of mouse ERG1 B potassium channel eliminates I(Kr) in adult ventricular myocytes and elicits episodes of abrupt sinus bradycardia.
Topics: Age Factors; Animals; Arrhythmia, Sinus; Bradycardia; Cation Transport Proteins; Disease Models, Animal; DNA-Binding Proteins; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gene Targeting; Heart Ventricles; Ion Transport; Long QT Syndrome; Mice; Mice, Knockout; Myocardium; Patch-Clamp Techniques; Phenethylamines; Potassium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Isoforms; RNA, Messenger; Sulfonamides; Trans-Activators | 2003 |
Pro- and antiarrhythmic effects of fast cardiac pacing in a canine model of acquired long QT syndrome.
Topics: Action Potentials; Animals; Cardiac Pacing, Artificial; Chromans; Disease Models, Animal; Dogs; Electrocardiography; Female; Heart Block; Long QT Syndrome; Male; Phenethylamines; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sulfonamides; Time Factors; Ventricular Function | 2004 |
Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Heart Atria; Heart Ventricles; Phenethylamines; Potassium Channel Blockers; Propafenone; Random Allocation; Sodium Channel Blockers; Sulfonamides | 2004 |
Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Hydantoins; Imidazolidines; Male; Phenethylamines; Piperazines; Rabbits; Sulfonamides; Torsades de Pointes | 2005 |
QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome.
Topics: Action Potentials; Animals; Anti-Infective Agents; Area Under Curve; Arrhythmias, Cardiac; Aza Compounds; Cell Line; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; Ether-A-Go-Go Potassium Channels; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Moxifloxacin; Phenethylamines; Potassium Channels, Inwardly Rectifying; Quinolines; Rabbits; Sulfonamides; Telemetry; Treatment Outcome | 2005 |
The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Disease Models, Animal; Electrophysiology; Extracellular Matrix; Female; Hydantoins; Hyperkalemia; Imidazolidines; Oocytes; Phenethylamines; Piperazines; Potassium Channels; Potassium Channels, Voltage-Gated; Probability; Sensitivity and Specificity; Sotalol; Sulfonamides; Xenopus laevis | 2007 |
Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.
Topics: Action Potentials; Anesthesia, General; Animals; Biphenyl Compounds; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Heart Block; Heart Rate; Heart Ventricles; Infusions, Intravenous; Male; Phenethylamines; Sulfonamides; Torsades de Pointes; Treatment Outcome | 2006 |
In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.
Topics: Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Function; Blood Flow Velocity; Carbachol; Cardiotonic Agents; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiologic Techniques, Cardiac; Female; Goats; Guinea Pigs; Heart Atria; Heart Ventricles; Humans; Inhibitory Concentration 50; Ion Channels; Male; Myocytes, Cardiac; Papillary Muscles; Patch-Clamp Techniques; Phenethylamines; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sulfonamides; Swine; Time Factors | 2007 |
Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
Topics: Animals; Anti-Arrhythmia Agents; Atrioventricular Block; Bradycardia; Cresols; Delayed Rectifier Potassium Channels; Disease Models, Animal; Electrocardiography; Female; Long QT Syndrome; Myocytes, Cardiac; Patch-Clamp Techniques; Phenethylamines; Phenylurea Compounds; Rabbits; Sulfonamides; Torsades de Pointes | 2008 |
Antifibrillary action of class I-IV antiarrhythmic agents in the model of ventricular fibrillation threshold of anesthetized guinea pigs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Chromans; Disease Models, Animal; Electric Stimulation; Electrocardiography; Encainide; Ethanolamines; Guinea Pigs; Heart; Heart Conduction System; Injections, Intravenous; Male; Metoprolol; Nebivolol; Phenethylamines; Piperidines; Sotalol; Sulfonamides; Ventricular Fibrillation; Verapamil | 1995 |
Antifibrillatory effects of clofilium in the rabbit isolated heart.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Decanoic Acids; Disease Models, Animal; Glyburide; Heart; Hydroxy Acids; In Vitro Techniques; Myocardium; Oxygen Consumption; Patch-Clamp Techniques; Phenethylamines; Potassium Channels; Quaternary Ammonium Compounds; Rabbits; Refractory Period, Electrophysiological; Sulfonamides; Ventricular Fibrillation; Ventricular Pressure | 1994 |
Antifibrillatory effects of BRL-32872 in anesthetized Yucatan minipigs with regional myocardial ischemia.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Benzamides; Disease Models, Animal; Flecainide; Injections, Intravenous; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenethylamines; Sulfonamides; Swine; Swine, Miniature; Ventricular Fibrillation | 1995 |
Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Flutter; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduction System; Phenethylamines; Quinidine; Sulfonamides; Treatment Outcome | 1996 |
Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Digitalis; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Epinephrine; Female; Male; Myocardial Infarction; Myocardial Reperfusion; Phenethylamines; Plants, Medicinal; Plants, Toxic; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 1996 |
Action potential prolongation and potassium currents in left-ventricular myocytes isolated from hypertrophied rabbit hearts.
Topics: Action Potentials; Animals; Barium Compounds; Cadmium Chloride; Cells, Cultured; Chlorides; Disease Models, Animal; Endocardium; Hypertension; Hypertrophy, Left Ventricular; Male; Patch-Clamp Techniques; Pericardium; Perinephritis; Phenethylamines; Potassium Channel Blockers; Potassium Channels; Rabbits; Sulfonamides; Ventricular Function | 1998 |
Inhibition of delayed rectifier K+ current by dofetilide and E-4031 differentially affects electrical cardiac responses to vagus stimulation in anesthetized dogs.
Topics: Animals; Anti-Arrhythmia Agents; Bradycardia; Disease Models, Animal; Disopyramide; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Female; Heart Conduction System; Male; Phenethylamines; Piperidines; Potassium Channel Blockers; Pyridines; Sulfonamides; Vagus Nerve | 1998 |
Dispersion of ventricular repolarization in left ventricular hypertrophy: influence of afterload and dofetilide.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Electrocardiography; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Myocardial Contraction; Phenethylamines; Potassium Channel Blockers; Rabbits; Sulfonamides; Ventricular Pressure | 1998 |
The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock.
Topics: Action Potentials; Aminobenzoates; Animals; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds, Heterocyclic; Defibrillators, Implantable; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electric Countershock; Electrocardiography; Female; Heart Rate; Infusions, Intravenous; Male; Phenethylamines; Pilot Projects; Potassium Channel Blockers; Potassium Channels; Sulfonamides; Treatment Outcome; Ventricular Fibrillation | 1999 |
Proarrhythmia of azimilide and other class III antiarrhythmic agents in the adrenergically stimulated rabbit.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Female; Hemodynamics; Hydantoins; Imidazoles; Imidazolidines; Male; Methoxamine; Phenethylamines; Piperazines; Procainamide; Quaternary Ammonium Compounds; Rabbits; Sotalol; Sulfonamides | 2000 |
Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Disease Models, Animal; Dogs; Electrocardiography; Heart Failure; Heart Ventricles; Pacemaker, Artificial; Pericardium; Phenethylamines; Sulfonamides; Ventricular Remodeling | 2000 |
Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Heart Block; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sulfonamides; Torsades de Pointes; Ventricular Function | 2001 |
Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Incidence; Long QT Syndrome; Male; Methoxamine; Models, Cardiovascular; Phenethylamines; Rabbits; Receptors, Adrenergic, alpha-1; Risk Factors; Sex Factors; Sulfonamides; Treatment Outcome; Women's Health | 2001 |
Electrophysiological mechanism of enhanced susceptibility of hypertrophied heart to acquired torsade de pointes arrhythmias: tridimensional mapping of activation and recovery patterns.
Topics: Animals; Anti-Arrhythmia Agents; Body Surface Potential Mapping; Cardiomegaly; Disease Models, Animal; Disease Susceptibility; Dogs; Dose-Response Relationship, Drug; Electrodes, Implanted; Electrophysiologic Techniques, Cardiac; Heart Block; Heart Conduction System; Membrane Potentials; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Torsades de Pointes | 2002 |
Effects of dofetilide on cardiovascular tissues from normo- and hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Blood Vessels; Cardiac Output, Low; Cardiomegaly; Disease Models, Animal; Electric Stimulation; Heart Rate; Heart Ventricles; Hypertension; In Vitro Techniques; Mesenteric Arteries; Myocardial Contraction; Phenethylamines; Portal Vein; Potassium Channel Blockers; Pulmonary Artery; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides | 2002 |